Serrato
Payments companies reported to CMS as associated with Serrato. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Serrato, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Serrato
These are the largest totals companies reported as associated with Serrato. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Alexander Vaccaro | Philadelphia, PA | Orthopaedic Surgery | $900,650.91 |
| Alexander Powers | Kernersville, NC | Neurological Surgery | $450,618.54 |
| Michael Ain | Lutherville, MD | Orthopaedic Surgery | $450,618.54 |
| Charles Sansur | Baltimore, MD | Neurological Surgery | $450,530.68 |
| Scott Luhmann | Saint Louis, MO | Pediatric Orthopaedic Surgery | $450,413.45 |
| Rod Oskouian | Seattle, WA | Neurological Surgery | $450,335.86 |
| James Sanfilippo | Moorestown, NJ | Orthopaedic Surgery of The Spine | $23,400.00 |
| Jason Savage | Cleveland, OH | Orthopaedic Surgery of The Spine | $23,285.62 |
| Daniel Refai | Atlanta, GA | Neurological Surgery | $19,500.00 |
| John Chi | Boston, MA | Neurological Surgery | $19,125.00 |
Prescribed Serrato?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.